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Abstract
Mixed features personality disorders (PDs) are highly prevalent and associated with significant burden of disease. Despite that, it has been an overlooked 
diagnostic category with respect to clinical research. This study aims to review empirical evidence about psychotherapy delivery available for these patients. We 
present a systematic review of clinical trials investigating the outcomes of psychotherapeutic interventions in adults with a primary diagnosis of mixed features 
PDs. Data were obtained from Medline/PubMed, Embase and PsycINFO. Seven studies met inclusion criteria; in one of them the whole sample was of this 
diagnostic group; two studies analysed psychotherapeutic intervention outcomes in this population, among other types of PDs, yet drawing specific conclusions 
on mixed features PDs patients; remaining studies addressed patient samples with different PDs types, mixed features included, where specific findings in this 
group of patients were not described – nonetheless, they included representative numbers of subjects with the diagnosis of interest. Available studies suggest 
that mixed features personality pathology per se does not seem to be an impediment to benefit from psychotherapeutic treatment, and improvement in different 
areas of life is possible for patients undergoing psychotherapy. The extant literature is marked by multiple challenges and inconsistencies across studies.
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Introduction
Psychotherapy is the treatment of choice for personality disorders 
(PDs). This can be concluded from clinical guidelines, meta-analyses, 
and systematic or critical literature reviews1. Other treatments, 
such as pharmacological interventions, have received less empirical 
support1,2.
According to the DSM-IV-TR, the category of Personality 
Disorder Not Otherwise Specified (PDNOS) can be used for 
“disorders of personality functioning that do not meet criteria for 
any specific personality disorder (…), the presence of features of 
more than one specific personality disorder that do not meet the full 
criteria for any one personality disorder (mixed personality), but that 
together cause clinically significant distress or impairment in one or 
more important areas of functioning”3. Recently, with the DSM-5, this 
category does not appear under this heading. The category of Other 
Specified Personality Disorder applies to similar presentations but 
is used in situations in which the clinician chooses to communicate 
the specific reason that the presentation does not meet the criteria for 
any specific personality disorder (…) by recording Other Specified 
Personality Disorder followed by the specific reason (e.g., “mixed 
personality features”)4.
Some of the structured diagnostic interviews have included 
directions for assigning a PDNOS diagnosis mixed type. In different 
approaches, it should be applied when the subject is one criterion 
below the diagnostic threshold for 2 or more PDs; it requires the 
presence of at least 10 criteria from the specific PDs; or it only 
requires that the subject meets traits from more than one specific PD, 
in addition to the general PD criteria5. On the other hand, Verheul 
et al. reported that a cut-off of 5 criteria yielded an additional group 
of PDNOS patients with a similar level of functional impairment as 
groups defined according to cut-offs of 10 or 15 PD criteria5,6. The 
assessment methods tend to produce different PDNOS prevalence 
rates7.
Numerous studies suggest that PDNOS is one of the most 
prevalent mental disorders in clinical practice8. A meta-analysis on 
the prevalence and use of PDNOS diagnoses showed that 3%-6% 
of the general population and 8%-13% of clinical samples met the 
diagnostic criteria for a PDNOS diagnosis. The relative prevalence, 
defined as the prevalence of PDNOS divided by the overall axis II 
percentage without PDNOS, was estimated at 21%-49%7. As is the 
case for patients with specific PD, the burden of disease of patients 
with PDNOS is high, and, in terms of quality of life, patients report a 
quality-of-life score on the EuroQol (EQ-5D) comparable to patients 
with haemodialysis, rheumatic disease, lung cancer, Parkinson’s 
disease or diabetes type II. The diagnosis is associated with high 
costs for society8.
In a general population study, Johnson et al. found that 
adolescents and young adults in the general population diagnosed 
with PDNOS may be as likely as those with Cluster A, B, or C PDs 
to have axis I psychopathology and to have behavioural, educational, 
or interpersonal problems that are not attributable to co-occurring 
psychiatric disorders9. In contrast, the multicenter study of Verheul 
et al. found that PDNOS took an intermediate position between 
cluster A, B, or C PDs and no PD, regarding severity of personality 
pathology, symptoms, and functional impairment6. Another clinical 
study by Karterud et al. also found that PDNOS was associated with 
less severe psychopathology and better treatment response compared 
to patients with specific PDs10. Moreover, a few case reports of patients 
with a PDNOS diagnosis have been published11-13.
Mixed features PDs have been an overlooked diagnostic category 
with respect to clinical research. Treatment studies typically focus 
on formal PDs and do not report results for these groups separately 
even when they are included in trials. According to our knowledge, 
there are very few treatment studies on mixed features PD patient 
groups, despite their high prevalence and high burden of disease, 
reasons why we took an interest in the subject.
Psychotherapeutic treatments can be delivered in various 
formats, settings, modalities, and dosages. This study aims to review 
the level of empirical evidence for different formats and settings that 
are available for psychotherapy delivery in mixed features personality 
disorders.
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Methods
This review was performed according to the PRISMA guidelines14, 
thus providing a comprehensive framework which objectively 
assesses indicators of quality and risk of biases of included studies.
Al l  or iginal  studies  invest igat ing the outcomes of 
psychotherapeutic interventions in adults (age between 18 and 
65 years) with a primary diagnosis of mixed features personality 
disorders were eligible for this systematic review. Further criteria 
adopted were: (1) publication date in the last decade, between January 
2007 and June 2017, (2) empirical study, and (3) written in English, 
Portuguese or Spanish language. Additionally, studies were excluded 
from review if they were: (1) single-case report, (2) review articles, 
(3) repeated study population, or (4) too small sample size (less than 
one-third of the total sample studied in cases where specific findings 
in mixed features PD are not described).
As this review focused on efficacy and effectiveness of 
interventions, naturalistic/non-controlled studies were included.
Studies were identified by searching relevant papers via PubMed/
Medline (http://www.ncbi.nlm.nih.gov/pubmed), PsycINFO and 
Embase using the following keywords in combination: “personality 
disorders”; “psychological treatment”, and “psychotherapy”. Finally, 
reference lists of retrieved studies were hand searched to identify any 
additional relevant studies. 
After performing the initial literature searches, each study title 
and abstract was screened for eligibility by the first author. Full texts 
of all potentially relevant studies were subsequently retrieved and 
further examined for eligibility. The PRISMA flow diagram (Figure 1) 
provides more detailed information regarding the selection process 
of studies. Information from the included studies was then analysed 
and recorded in an electronic spreadsheet designed by the first author. 
Different types of data were extracted from each study including: 
(a) country in which the data were collected, (b) participants’ 
characteristics (including diagnosis, age and gender), (c) number 
of subjects, (d) type of intervention (including modality, setting and 
duration of treatment) (e) type of outcome measure, (f) main results, 
and (g) study limitations.
ROBINS-I and Cochrane Collaboration’s tool for assessing 
risk of bias were adopted to evaluate the risk of bias in individual 
studies15,16. The following risk of biases were analysed: (1) bias 
due to confounding, (2) bias in selection of participants, (3) bias 
in classification of interventions, (4) bias due to deviations from 
intended interventions, (5) bias due to missing data, (6) bias in 
measurement of outcomes, and (7) bias in selection of reported 
results. The assessments were completed by the first and third authors 
independently.
Results
Seven articles investigating the outcomes of psychotherapeutic 
interventions in adults with primary diagnosis of mixed features PDs 
were included in this review. One of them specifically focused on this 
diagnostic group, which corresponds to the study’s whole sample8. 
Two other studies analysed the effectiveness of psychotherapeutic 
interventions in mixed features PDs, among other PDs types, yet 
drawing concrete conclusions for this specific patient subgroup17,18. 
The remaining four studies19-22 were concerned with intervention 
outcomes in samples of patients with different PDs types, mixed 
features personality disorders included, where specific findings about 
this patient group were not described. Despite that, they included a 
representative number of subjects with the diagnosis of interest (at 
least one-third of the total sample studied) and, henceforth, its results 
were of interest to this review.
Four studies were from The Netherlands, two were from Norway, 
and one from Poland. Reviewed studies included 399 participants 
with a primary diagnosis of mixed features PD. Considering that six 
of the studies include varied samples and not only the mentioned 
diagnosis, known data related to gender distribution and average age 
are relative to whole samples and not only to this subgroup.
A summary of results is presented in Table 1 and risk of 
bias in individual studies based on ROBINS-I and Cochrane 
Collaboration’s tool for assessing risk of bias is presented in Table 2. 
As shown in this table, deviations from intended interventions was 
the most frequent bias, with six of seven studies assessed having 
moderate risk for this type of bias. No bias due to confounding and 
in selection of reported result were found, although the risk of bias 
was not always clear.Figure 1. PRISMA flow diagram of the study selection process.
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Table 1. Effectiveness of psychotherapeutic interventions in adults with primary diagnosis of mixed features personality disorders
Study Country;
Study design
Subjects Type of intervention Type of outcome measure; Main 
findings
Study limitations
Horn et al., 
20158
The Netherlands;
Multicenter quasi-
experimental
PDNOS N = 205 
(100% of the sample):
– PD mixed only 
(65%);
– Appendix PD only 
(17%);
– PD mixed and 
appendix PD (18%)
Mean age 35.1 (SD 
= 10.3) years 72% 
female.
Short-term (≤ 6 months) and 
long-term (> 6 months) outpatient, 
day hospital and inpatient 
psychotherapy
Psychodynamic (27%), cognitive-
behavioural (21%) or integrative 
orientation (52%) 60 months 
follow-up.
Symptom severity; Psychosocial 
functioning; Quality of life
Patients in all treatment modalities 
showed positive outcomes 
at short-term and long-term 
follow-ups, especially in terms of 
improvements of symptom severity 
and social role functioning.
Short-term outpatient 
psychotherapy and short-term 
inpatient psychotherapy seem to 
be superior at 12-month follow-
up. At 60-month after baseline, 
effectiveness remained but 
observed differences between 
modalities mostly diminished. 
Not a randomized controlled trial.
Difference of loss to follow-up.
Did not take into acount other 
treatment attributes – potential 
impact of theoretical orientation 
and medication use, or patient 
attributes – axis I comorbidity.
Effectiveness is determined by 
self-report, without information 
if whether patients still meet 
criteria for a PD diagnosis after 
5 years.
Sites overlapped only partially in 
terms of the (equal) availability 
of the six modalities.
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Study Country;
Study design
Subjects Type of intervention Type of outcome measure; Main 
findings
Study limitations
Horn et al., 
201517
The Netherlands;
Matched-control study
PDNOS N = 61 
(42% of the STIP-TA 
patients and 49% of 
the OP patients)
Mean age 39.4 (SD 
9.8) years in STIP-TA 
patients, and 39.3 (SD 
10.2) in OP patients 
70% female.
Short-term (3-month) inpatient 
Psychotherapy based on 
transactional analysis (STIP-
TA) and other psychotherapies 
(OP) varying widely in terms of 
setting, duration, and theoretical 
orientation 36 months follow-up.
General psychiatric 
symptomatology; Psychosocial 
functioning; Quality of life
At 36 months, 68% of STIP-TA 
patients were symptomatically 
recovered compared to 48% of OP 
patients. STIP-TA outperformed 
OP in terms of improvements 
in general psychiatric 
symptomatology and quality of life. 
Superiority of STIP-TA was most 
pronounced at 12-month follow-
up, but remained intact over the 
course of the 3-year follow-up.
A very promising and effective 
treatment option in mainly 
PDNOS patients.
Not a randomized controlled 
trial.
Only self-report instruments 
used as outcome measures.
Information about the treatment 
fidelity and adherence was not 
collected.
The interpretation of the results 
is limited by the variation of 
treatment modalities in the OP 
condition. 
Kvarstein et 
al., 201718
Norway;
Naturalistic study
PDNOS N = 18
(17.4% of the sample)
Mean age 38.5 (SD 
10) years 60% female.
Outpatient 
Psychodynamic groups, mean 
treatment duration 1.5 (SD 0.9) 
years 3-year follow-up.
Symptom distress; Interpersonal 
problems; Occupational 
functioning; Psychiatric health 
service use.
PDNOS benefits across all 
outcomes. The most favourable 
outcomes were found for patients 
with PDNOS.
PDNOS patients may be well 
managed within outpatient group 
therapy.
Naturalistic designs limits 
inferences on outcome as an 
effect of the treatment.
Dual roles of clinicians and 
researches may also limit validity 
of patient reported ratings.
Diagnostic procedures held a 
high standard, but reliability was 
not investigated.
Chakhssi et 
al., 201519
The Netherlands;
Nonrandomized 
exploratory study
PDNOS N = 38 (48.3% 
of the ACT patients 
and 42.9% of the CBT-
TAU patients)
Mean age 32.88 (SD 
10.13) years in ACT 
patients, and 33.26 
(SD 9.63) in CBT-
TAU patients 82.7% 
female.
Specialized day hospital setting 
for patients with personality 
disorders that did not respond 
to previous treatments 26-week 
group-based acceptance and 
commitment therapy (ACT).
Same duration group-based 
treatment-as-usual based on 
cognitive behaviour therapy 
(CBT-TAU)
Both supplemented by arts 
therapy, including creative and 
drama therapy, and rehabilitation 
counselling.
Change in personality pathology; 
General psychological functioning; 
Experimental avoidance; Coping 
skills; Positive outcomes; Quality 
of life
Group-based interventions for 
treatment-resistant patients 
with personality disorders led 
to significant improvements in 
personality pathology, general 
psychological functioning, 
coping skills and quality of life, 
regardless of whether participants 
received ACT or CBT-TAU.
In group analysis, no main effect 
of therapy condition was observed 
on the outcome measures.
Assessment of change on an 
individual level showed that a 
significantly higher percentage 
of participants receiving ACT 
improved on personality pathology.
Patients were not randomized.
Treatment fidelity was not 
assessed.
The unequal sample size across 
groups may have affect the 
results.
The patients were not only 
provided with ACT or CBT-TAU 
but also with other treatments, 
and the effect of these 
treatments on the outcomes 
remains unknown.
Medication use during the study 
was not measured.
No independent data was 
available on the type and quality 
of previous outpatient treatment 
interventions.
Do not report results for the 
PDNOS group separately.
Schaap et 
al., 201620
The Netherlands;
Naturalistic 
prospective study
PDNOS N = 24 
(42.9% of treatment 
completers and 26.1% 
of dropouts)
Mean age 26.94 (SD 
6.45) years 72.3% 
female.
12 months group schema therapy 
(ST) inpatient for patients with 
PDs who did not respond to 
previous psychotherapy
Specific ST techniques, 
psychodrama, art, movement and 
music therapies, social services, 
pharmacotherapy,
education about medication 6 
months follow-up.
Maladaptive schemas; Schema 
modes; Maladaptive coping 
styles; Mental well-being; 
Psychological distress after 
treatment 
Over participants improved 
significantly on all outcome 
measures from pretreatment 
to posttreatment, and these 
improvements were maintained at 
follow-up.
Experienced parenting styles 
was the one area that showed no 
improvement.
These findings are comparable 
with treatment results for patients 
without such a nonresponsive 
treatment history.
Lack of a control-group.
Treatment fidelity was not 
assessed.
The patients were not only 
provided with ST, but also with 
additional therapies.
Diagnosis were based on the 
clinical judgement and not by 
structured interviews.
The relationship between 
the YSQ (Young schema 
questionnaire) and SMI (Short 
schema mode inventory) was 
large.
Do not report results for the 
PDNOS group separately.
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Study Country;
Study design
Subjects Type of intervention Type of outcome measure; Main 
findings
Study limitations
Cyranka et 
al., 201621
Poland;
Naturalistic study
Mixed features PDs 
N = 34:
– Other PDs (24% of 
the sample);
– Mixed and other 
PDs (15% of the 
sample);
– PDs unspecified (2% 
of the sample)
Mean age 31.5 (SD 
6.9) years 74% female
10-14 weeks intensive short-term 
group psychotherapy in a day 
ward with elements of individual 
therapy
Integrated the elements of 
psychodynamic, cognitive and 
behavioural theories
Personality functioning using 
MMPI-2 clinical scales.
Having undergone the 
psychotherapy treatment, the 
majority of the examined were 
observed to demonstrate positive 
changes in personality functioning 
which were classified as severe 
or moderate pathology.
Lack of a control-group.
Not carrying out a follow-up 
study.
Not extending the analysis with 
other questionnaire scales.
Do not report results for the 
mixed features PDs group 
separately.
Hoglend et 
al., 201122
Norway;
Randomized 
controlled clinical trial
PDNOS N = 19 (35% 
of transference 
group and 49% of 
comparison group)
Mean age 34.9 
(SD 8.7) years in 
transference patients, 
and 32.7 (SD 9.5) in 
comparison patients 
63% female.
1 year of dynamic psychotherapy 
with low to moderate use of 
transference interpretations 
(transference group).
Dynamic psychotherapy without 
this component (comparison 
group).
Both with other treatments 
components such as clarifications, 
confrontations and extra-
transference interpretations.
Remission from personality 
disorder; Improvement in 
interpersonal functioning; Use of 
mental health resources in the 
3-year period after treatment 
termination.
After therapy with transference 
interpretation, PD-patients 
improved significantly more 
in core psychopathology and 
interpersonal functioning, the 
drop-out rate was reduced to 
zero, and use of health services 
was reduced to 50%, compared to 
therapy without this ingredient.
Three years after treatment 
termination, 73% no longer met 
diagnostic criteria for any PD in 
the transference group, compared 
to 44% in the comparison group.
Only clinician-rated outcome 
measures were used.
No longer meeting full criteria 
for any PD may be seen as a 
problematic measure of recovery, 
since it also may include patients 
who just drop one criterion 
below the cut-off scores for a 
definite diagnosis.
Primary outcome (recovery from 
PD) was based on non-blind 
ratings.
Do not report results for the 
PDNOS group separately.
Table 2. Assessment of risk of bias in individual studies
Study Bias due to 
Confounding
Bias in Selection 
of Participants
Bias in 
Classification of 
Interventions
Bias due to 
Deviations 
from Intended 
Interventions
Bias due to 
Missing Data
Bias in 
Measurement of 
Outcomes
Bias in Selection 
of the Reported 
Result
Horn et al.8 Low Moderate Moderate Moderate Moderate Low Low
Horn et al.17 Low Moderate Moderate Moderate Moderate Low Low
Kvarstein et al.18 Low Low Low Moderate Low Moderate Low
Chakhssi et al.19 Low Moderate Low Moderate Low Low Low
Schaap et al.20 Low Low Low Moderate Low Moderate Low
Cyranka et al.21 Low Moderate Low Moderate Moderate Moderate Low
Hoglend et al.22 Low Moderate Low Low Low Low Low
Discussion
Being psychotherapy the treatment of choice for personality 
disorders, and with so few treatment studies on mixed features PDs, 
despite their high prevalence and high burden, the authors addressed 
and reviewed empirical evidence for different formats, settings, 
modalities and dosages that are available for psychotherapy delivery 
in adults with this primary diagnosis. Psychotherapy treatment 
studies typically focus on specific PDs types, with borderline PD 
being more extensively studied than any other PD; results for mixed 
features PDs are unfrequently reported in separate, even when they 
are included in trials.
We chose to include: (1) studies that analysed psychotherapeutic 
intervention outcomes in these patients, even among samples with 
other types of PDs, drawing concrete conclusions for the group, and 
(2) studies where specific findings in this group of patients are not 
reported as long as they included a representative number of subjects 
with this diagnosis (at least one-third of the total sample studied), so 
the results could be somehow applicable to this subgroup. Eighteen 
full-text articles assessed for eligibility were excluded due to small 
(up to 21% participants) sample size, making its results extrapolation 
inadequate.
Horn et al.8 specifically focuses on PDNOS patients, a group that 
corresponded to the total studied sample. It was the first large-scale 
treatment study in patients with PDNOS, having investigated the 
effectiveness of different psychotherapy modalities in patients with 
PDNOS, i.e., short-term and long-term outpatient, day hospital and 
inpatient psychotherapy. The treatments offered included varied 
theoretical orientations, such as psychodynamic orientation (27% of 
all given treatments), a cognitive-behavioural orientation (21% of all 
given treatments) or an integrative orientation (combining different 
theoretical frameworks, 52% of all given treatments). Patients in 
all treatment modalities showed positive outcomes at short-term 
and long-term follow-ups, especially in terms of improvements of 
symptom severity and social role functioning. Short-term outpatient 
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psychotherapy and short-term inpatient psychotherapy seem to be 
superior at 12-month follow-up, and at 60-month after baseline, 
effectiveness remained but observed differences between modalities 
mostly diminished.
In fact, cognitive-behavioural and psychodynamic approaches have 
been the object of the most extensive research in patients with PDs.
Cognitive behavioural therapy (CBT) is well suited to address 
the varied and often long-standing problems of patients with PDs for 
several reasons. From a cognitive behavioural perspective, PDs are 
maintained by a combination of maladaptive beliefs about self and 
others; contextual/environmental factors that reinforce problematic 
behaviour and/or undermine effective behaviour; and skill deficits 
that preclude adaptive responding. CBT incorporates a wide range of 
techniques to modify these factors, including cognitive restructuring, 
behaviour modification, exposure, psychoeducation, and skills 
training. In addition, CBT for PDs emphasizes the importance of a 
supportive, collaborative, and well-defined therapeutic relationship, 
which enhances the patient’s willingness to make changes and serves 
as a potent source of contingency. In sum, several aspects of CBT’s 
conceptual framework and its technical flexibility make it appropriate 
to address the pervasive and diffuse impairment commonly observed 
among patients with PDs23,24.
Psychoanalytic psychotherapy, also referred to as psychodynamic 
psychotherapy, is a type of therapy that incorporates concepts such 
as the unconscious, the use of defense mechanisms, and the role of 
an individual’s past via their social processes such as attachment 
and early childhood experience. The approach provides useful 
tools for expanding, consolidating, and enriching one’s own life 
and one’s relationships with others. Contemporary psychodynamic 
therapy involves many Freudian concepts, such as the existence of 
the unconscious, yet it has also moved away from a purely Freudian 
focus on drive, ego, and conflict. Contemporary psychodynamic 
theory includes a rich body of theory, and now incorporates various 
aspects of many 20th century psychoanalytic theories including object 
relations, self-psychology, interpersonal/relational theory, attachment 
theory, trauma theory, and intersubjective theory25.
In another study, Horn et al.17 compared 3-month short-term 
inpatient psychotherapy based on transactional analysis (STIP-TA) 
with other psychotherapies (OP) up to 36-month follow-up. At 36 
months, 68% of STIP-TA patients were symptomatically recovered 
compared to 48% of OP patients. This therapy outperformed OP in 
terms of improvements in general psychiatric symptomatology and 
quality of life. That superiority was most pronounced at 12-month 
follow-up but remained intact over the course of the 3-year follow-up. 
The authors concluded that it could be a very promising and effective 
treatment option in mainly PDNOS patients, which corresponded to 
42% of the STIP-TA patients and 49% of the OP patients. Kvarstein et 
al.18 also conclude that PDNOS patients may be well managed within 
outpatient group therapy, in a trial involving outpatient psychodynamic 
groups with mean treatment duration 1.5 years and 3-year follow-up 
evaluating symptom distress, interpersonal problems, occupational 
functioning, and psychiatric health service use. The most favourable 
outcomes were found exactly for patients with PDNOS.
The remaining four studies included for review19-22 do not report 
results for the mixed features PDs patients group separately. Both 
Chakhssi et al.19 and Schaap et al.20 studied PDNOS patients, among 
others, that did not respond to previous treatments. The first compared 
day hospital group-based acceptance and commitment therapy 
(ACT) and group-based treatment-as-usual based on cognitive 
behaviour therapy (CBT-TAU), led to significant improvements in 
personality pathology, general psychological functioning, coping 
skills and quality of life in both groups. The second author and 
colleagues evaluated the outcomes of an impatient group schema 
therapy (ST) in maladaptive schemas, schema modes, maladaptive 
coping styles, mental well-being, and psychological distress after 
treatment. Overall, participants improved significantly on all 
outcome measures from pretreatment to posttreatment, and these 
improvements were maintained at 6-month follow-up. Experienced 
parenting styles was the one area that had no improvement.
Cyranka et al.21 evaluated intensive short-term group psychotherapy 
in a day ward with elements of individual therapy, integrating the 
elements of psychodynamic, cognitive and behavioural theories, in 
mixed features PDs patients, which demonstrated positive changes in 
personality functioning which were classified as severe or moderate 
pathology. Hoglend et al.22 carried out the only randomized controlled 
trial included in this review, comparing 1 year of dynamic psychotherapy 
with low to moderate use of transference interpretations and dynamic 
psychotherapy without this component in a sample including 
PDNOS patients. After therapy with transference interpretation, 
patients improved significantly more in core psychopathology and 
interpersonal functioning, the drop-out rate was reduced to zero, 
and use of health services was reduced to 50%, compared to therapy 
without this ingredient. Three years after treatment termination, 73% 
no longer met diagnostic criteria for any PD in the transference group, 
compared to 44% in the comparison group.
Researchers have highlighted the diversity of treatments as an 
obstacle to identifying efficacious treatments26. In addition, some 
authors emphasize that instead of conducting further comparisons 
of different treatments, research should be concentrated on the active 
ingredients of treatments17, 27.
Various independent psychotherapies demonstrated efficacy 
for these patients. However, several factors limit our ability to draw 
strong conclusions from available research. Overall, the limited 
number of studies included, with only one randomized controlled 
trial, is insubstantial. Although certainly lacking the rigor of RCTs, 
uncontrolled studies can provide clinically important information 
about mechanisms of change and moderators of treatment outcome. 
In addition to their use for driving theory and hypotheses for testing 
in future RCTs, uncontrolled studies can be useful for uncovering 
essential qualities of effective interventions and the effectiveness 
of psychotherapy as it is delivered in the field. Furthermore, co-
occurring of other disorders, particularly within Axis I conditions, 
the possibility that maturational processes or life events may 
be responsible for part of the changes measured, and the use of 
medications along with the psychotherapy, further hampers existing 
research. An additional concern is substantial heterogeneity among 
studies included in the review. Besides, differences with respect to 
therapy format, the length, patient samples, gender distribution, and 
length of follow-up periods are very variable.
Subgroup analysis directed at “what works for whom” could 
give more valuable information for clinical practice about which 
treatments work best for which category of patients instead for which 
category of diagnosis. This is even more important in this patient 
group since various definitions of PDNOS are used in clinical practice 
and across studies, limiting the comparability and generalizability 
of study findings5,7,8,28.
Despite previously mentioned limitations, findings from recent 
studies make an important contribution to our understanding of the 
role of psychotherapy in mixed features PDs.  
Conclusions
Despite the toll of mixed features PDs on healthcare systems, there are 
vast gaps in the treatment literature on these disorders, a frequently 
overlooked mental health problem, for which there are no established 
psychosocial treatments.
Overall, there are some psychotherapeutic approaches with 
different modalities and durations offered to these individuals, 
and the research findings we reviewed suggest that there is hope 
for significant and meaningful changes after psychotherapy in 
individuals with PDNOS.
The most important conclusion is that mixed features personality 
pathology per se does not seem to be an impediment to benefit from 
psychotherapy, and improvement in different areas of life is possible 
for the patients who undergo psychotherapeutic treatment. It would 
be important to make psychotherapy more accessible for this patient 
group in order to reach health gains for this vulnerable group of 
psychiatric patients. 
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Although promising in many ways, the extant literature is marked 
by multiple challenges and inconsistencies across studies. Further 
research on the effectiveness of psychotherapy for mixed features 
PD patients is undoubtedly needed.
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